ATE468329T1 - Isoxazolderivate und deren verwendung als cyclooxygenaseinhibitoren - Google Patents

Isoxazolderivate und deren verwendung als cyclooxygenaseinhibitoren

Info

Publication number
ATE468329T1
ATE468329T1 AT05702217T AT05702217T ATE468329T1 AT E468329 T1 ATE468329 T1 AT E468329T1 AT 05702217 T AT05702217 T AT 05702217T AT 05702217 T AT05702217 T AT 05702217T AT E468329 T1 ATE468329 T1 AT E468329T1
Authority
AT
Austria
Prior art keywords
cyclooxygenase inhibitors
isoxazole derivatives
cyclooxygenase
inhibitors
cox
Prior art date
Application number
AT05702217T
Other languages
English (en)
Inventor
Antonio Scilimati
Nunno Leonardo Di
Paola Vitale
Paola Patrignani
Stefania Tacconelli
Ettore Porreca
Liborio Stuppia
Original Assignee
Univ Bari
Uni Degli Studi Di Chieti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Bari, Uni Degli Studi Di Chieti filed Critical Univ Bari
Application granted granted Critical
Publication of ATE468329T1 publication Critical patent/ATE468329T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT05702217T 2004-01-12 2005-01-12 Isoxazolderivate und deren verwendung als cyclooxygenaseinhibitoren ATE468329T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000019A ITMI20040019A1 (it) 2004-01-12 2004-01-12 Derivati isossazolici e loro impiego come inibitori della ciclossigenasi
PCT/IB2005/000047 WO2005068442A2 (en) 2004-01-12 2005-01-12 Isoxazole derivatives and their use as cyclooxygenase inhibitors

Publications (1)

Publication Number Publication Date
ATE468329T1 true ATE468329T1 (de) 2010-06-15

Family

ID=34779432

Family Applications (2)

Application Number Title Priority Date Filing Date
AT05702217T ATE468329T1 (de) 2004-01-12 2005-01-12 Isoxazolderivate und deren verwendung als cyclooxygenaseinhibitoren
AT10005150T ATE538107T1 (de) 2004-01-12 2005-01-12 Isoxazol-derivate zur anwendung als cyclooxygenase-inhibitoren

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT10005150T ATE538107T1 (de) 2004-01-12 2005-01-12 Isoxazol-derivate zur anwendung als cyclooxygenase-inhibitoren

Country Status (7)

Country Link
EP (2) EP2246337B1 (de)
AT (2) ATE468329T1 (de)
DE (1) DE602005021309D1 (de)
DK (1) DK1706390T3 (de)
ES (1) ES2344738T3 (de)
IT (1) ITMI20040019A1 (de)
WO (1) WO2005068442A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7943588B2 (en) 2006-03-28 2011-05-17 Trustees Of Dartmouth College Method for preventing or treating neuropathic pain
US7989450B2 (en) 2008-01-11 2011-08-02 Universita' Degli Studi Di Bari Functionalized diarylisoxazoles inhibitors of ciclooxygenase

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1128526A (en) * 1979-10-05 1982-07-27 Cdc Life Sciences Inc. 3,4-diarylisoxazol-5-acetic acids
JPH04134077A (ja) * 1990-09-21 1992-05-07 Taiho Yakuhin Kogyo Kk イソオキサゾール化合物
US5399577A (en) * 1991-05-01 1995-03-21 Taiho Pharmaceutical Co., Ltd. Isoxazole derivatives and salts thereof
AU699593B2 (en) * 1995-02-13 1998-12-10 G.D. Searle & Co. Substituted isoxazoles for the treatment of inflammation
ATE309228T1 (de) * 1997-04-21 2005-11-15 Sumitomo Pharma Isoxazolderivate
US6600052B1 (en) * 2000-04-25 2003-07-29 Pharmacia Corporation Regioselective synthesis of 3,4-di(carbocyclyl or heterocyclyl)thiophenes
US20030105144A1 (en) * 2001-04-17 2003-06-05 Ping Gao Stabilized oral pharmaceutical composition
US6673818B2 (en) * 2001-04-20 2004-01-06 Pharmacia Corporation Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation
EP1438300A1 (de) * 2001-10-02 2004-07-21 Pharmacia Corporation Verfahren zur herstellung von benzolsulfonylverbindungen
US6809204B2 (en) * 2001-10-12 2004-10-26 Onconova Therapeutics, Inc. Processes for the preparation of substituted isoxazoles and 2-isoxazolines
MXPA04008932A (es) * 2002-03-15 2004-11-26 Pharmacia Corp Parecoxib sodico cristalino.
ATE422201T1 (de) * 2002-04-05 2009-02-15 Cadila Healthcare Ltd 4-(heterocyclyl)-benzenesulfoximin verbindungen zur behandlung entzündlicher erkrankungenen
DE10237883A1 (de) * 2002-08-19 2004-03-04 Merckle Gmbh Chem.-Pharm. Fabrik Substituierte Isoxazolderivate und ihre Verwendung in der Pharmazie
CA2503063A1 (en) * 2002-10-22 2004-05-06 Merck Frosst Canada & Co./Merck Frosst Canada & Cie Nitric oxide releasing selective cyclooxygenase-2 inhibitors
HUP0302219A2 (hu) * 2003-07-16 2005-03-29 Richter Gedeon Vegyészeti Gyár Rt. N-hidroxi-4-(3-fenil-5-metil-izoxazol-4-il)-benzolszulfonamid-szolvátok, eljárás előállításukra és alkalmazásuk

Also Published As

Publication number Publication date
EP1706390A2 (de) 2006-10-04
DE602005021309D1 (de) 2010-07-01
ES2344738T3 (es) 2010-09-06
DK1706390T3 (da) 2010-08-23
WO2005068442A2 (en) 2005-07-28
EP2246337B1 (de) 2011-12-21
ITMI20040019A1 (it) 2004-04-12
ATE538107T1 (de) 2012-01-15
WO2005068442A3 (en) 2006-04-06
EP2246337A1 (de) 2010-11-03
EP1706390B1 (de) 2010-05-19

Similar Documents

Publication Publication Date Title
ATE459605T1 (de) Isoxazolinderivate und deren verwendung als herbizide
DE602005018084D1 (de) Isoxazolinderivate und ihre verwendung als herbizide
CY1113276T1 (el) Μυκητοκτονες συνθεσεις
ATE520686T1 (de) Azabicycloä3.1.0ühexanderivate und ihre verwendung als modulatoren des dopamin-d3- rezeptors
ATE548374T1 (de) 2'-fluor-2'-desoxytetrahydrouridine als cytidindeaminaseinhibitoren
ATE442348T1 (de) Amino substituierte phenylessigsäuren sowie deren derivate, deren herstellung und deren verwendung als cyclooxygenase 2 (cox-2) inhibitoren
CY1114095T1 (el) Μυκητοκτονες συνθεσεις
CY1110026T1 (el) Ενωσεις πιπεραζινης βενζισοξαζολης και μεθοδοι χρησης εξ αυτων
NO20053215D0 (no) Pyrazolderivater med anvendelse som COX-1-inhibitorer.
DE602005015699D1 (de) Prolinderivate und deren verwendung als dipeptidylpeptidase-iv-inhibitoren
CR10611A (es) Isoxazolinas insecticidas
CY2015007I1 (el) Ενωσεις, συνθεσεις και χρησεις παραγωγων βενζοθειαζολης
BRPI0617479A2 (pt) método e composição útil para manter ou melhorar a saúde gastrintestiinal de um animal, kit, meio para comunicação de informações ou instruções, e, uso de uma composição
DE602006013878D1 (de) Heterocyclische verbindungen, ihre herstellung und ihre verwendung als antibakterielle mittel
BRPI0813341A2 (pt) " uso de compostos, composições curáveis, e, uso de composições curáveis ".
ATE442366T1 (de) Oxazolidinonderivate und ihre verwendung als antibiotika
CY1113916T1 (el) Παραγωγα ετεροαρυλο πυρρολιδινυλο και πιπεριδινυλο κετονης
ATE399168T1 (de) Imidazopyridin-derivate und ihre verwendung als induzierbare no-synthase inhibitoren
DE602006008937D1 (de) N-amidderivate von 8-azabicycloä3.2.1üoct-3-yl als ccr1-antagonisten
ITMI20051957A1 (it) Composti e relativo uso per il controllo di fitoparogeni
ATE468329T1 (de) Isoxazolderivate und deren verwendung als cyclooxygenaseinhibitoren
ATE368654T1 (de) Benzothiazol- und benzoxazol-4,7-dionderivate und ihre verwendung als cdc25-phosphatasen- inhibitoren
DE602005005638D1 (de) 2-(piperidin-4-yl)-4,5-dihydro-2h-pyridazin-3-on-derivate als pde4-inhibitoren
DE602004015628D1 (de) Imidazopyridinderivate als induzierbare no-synthaseinhibitoren
ATE508130T1 (de) 3-oxa-10-aza-phenanthrene als pde4- oder pde3/4- inhibitoren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties